Eli Lilly : LLY

All Eli Lilly Articles

670 Articles

Lee Jackson | Oct 6, 2016 at 8:20 AM EDT

4 Merrill Lynch US 1 Stocks to Buy That Also Pay Solid Dividends

One smart thing for growth stock buyers is to focus on total return and buy large cap quality stocks that…

Chris Lange | Oct 5, 2016 at 10:35 AM EDT

Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition

Eli Lilly shares had a bit of a boost on Wednesday after it was announced that one of its subsidiaries…

Lee Jackson | Oct 5, 2016 at 8:20 AM EDT

Merrill Lynch Out With 10 Top US Stock Ideas for Q4

A recent Merrill Lynch research report features the firm's top ideas for the fourth quarter. These eight stocks look like…

Lee Jackson | Sep 30, 2016 at 8:25 AM EDT

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less…

Jon C. Ogg | Sep 29, 2016 at 12:10 PM EDT

2 Animal Health Stocks Still Look Attractive for Investors

If there is one trend that has worked in America, it is the trend of betting on the public taking…

Lee Jackson | Sep 28, 2016 at 10:05 AM EDT

Merrill Lynch Makes a Huge Change to Prestigious US 1 Portfolio

In a recent research note, the analysts at Merrill Lynch make a big move by adding a top utility company…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Lee Jackson | Sep 12, 2016 at 8:20 AM EDT

4 Safe Large Cap Dividend Stocks to Buy as Market Risk Increases

Investors never take kindly to a 2.45% sell-off, like the one seen in the S&P 500, and they may be…

Jon C. Ogg | Aug 15, 2016 at 1:05 PM EDT

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for…

Lee Jackson | Aug 5, 2016 at 10:20 AM EDT

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in…

Chris Lange | Jul 26, 2016 at 10:10 AM EDT

Why Eli Lilly Earnings Are So Dynamic

As one of the largest pharmaceutical companies on the street, Eli Lilly helps to set the tempo for the industry.…

Lee Jackson | Jul 26, 2016 at 8:35 AM EDT

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new…

Lee Jackson | Jul 16, 2016 at 9:15 AM EDT

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great…

Douglas A. McIntyre | Jul 9, 2016 at 9:25 AM EDT

Viagra Price Drops 50% as Drug Faces Competition

Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.

Chris Lange | Jun 29, 2016 at 11:47 AM EDT

Eli Lilly Rises on Positive FDA Committee Vote

Eli Lilly and Co. (NYSE: LLY) is watching its shares make a decent gain on Wednesday following a U.S. Food…

1 … 28 29 30 31 32 … 45

Eli Lilly : LLY

All Eli Lilly Articles

4 Merrill Lynch US 1 Stocks to Buy That Also Pay Solid Dividends

Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition

Merrill Lynch Out With 10 Top US Stock Ideas for Q4

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

2 Animal Health Stocks Still Look Attractive for Investors

Merrill Lynch Makes a Huge Change to Prestigious US 1 Portfolio

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

4 Safe Large Cap Dividend Stocks to Buy as Market Risk Increases

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

Why Eli Lilly Earnings Are So Dynamic

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Viagra Price Drops 50% as Drug Faces Competition

Eli Lilly Rises on Positive FDA Committee Vote

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

Eli Lilly : LLY

All Eli Lilly Articles

4 Merrill Lynch US 1 Stocks to Buy That Also Pay Solid Dividends

Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition

Merrill Lynch Out With 10 Top US Stock Ideas for Q4

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

2 Animal Health Stocks Still Look Attractive for Investors

Merrill Lynch Makes a Huge Change to Prestigious US 1 Portfolio

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

4 Safe Large Cap Dividend Stocks to Buy as Market Risk Increases

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

Why Eli Lilly Earnings Are So Dynamic

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Viagra Price Drops 50% as Drug Faces Competition

Eli Lilly Rises on Positive FDA Committee Vote

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account